1. Home
  2. Clinical Topics
  3. Amgen, FDA announce voluntary recall of Epogen and Procrit
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

Amgen, FDA announce voluntary recall of Epogen and Procrit

Share

On Sept. 24, Amgen and the U.S. Food and Drug Administration announced that Amgen is voluntarily recalling certain lots of Epogen and Procrit (Epoetin alfa) because the bottles may contain flakes of glass. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts